Calcium Binding Protein P22 (CHP) (N-Term) Peptid
CHP
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle CHP Produkte
- CHP (Calcium Binding Protein P22 (CHP))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- FTSLDKGENG TLSREDFQRI PELAINPLGD RIINAFFPEG EDQVNFRGFM
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-CHP Antibody(ARP52307_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CHP (Calcium Binding Protein P22 (CHP))
- Hintergrund
-
This gene encodes a phosphoprotein that binds to the Na+/H+ exchanger NHE1. This protein serves as an essential cofactor which supports the physiological activity of NHE family members and may play a role in the mitogenic regulation of NHE1. The protein shares similarity with calcineurin B and calmodulin and it is also known to be an endogenous inhibitor of calcineurin activity.
Alias Symbols: SLC9A1BP, CHP
Protein Interaction Partner: GAPDH,KIF1B,PRSS23,SLC9A1,SLC9A2,SLC9A3,SLC9A4,SLC9A5,STK17B,PRSS23,SLC9A1,SLC9A2,SLC9A3,SLC9A4,SLC9A5
Protein Size: 195 - Molekulargewicht
- 22 kDa
- Gen-ID
- 11261
- NCBI Accession
- NM_007236, NP_009167
- UniProt
- Q99653
-
Sie sind hier:
